NFKB1 and rheumatoid arthritis: found that lincRNA-p21 was down-regulated and NF-κB activation marker phosphorylated p65 was up-regulated by analyzing blood samples and cell culture models from patients with RA; lincRNA-p21 could inhibit NF-κB activity directly.